NO932031L - Substituerte (benzotiazolyl- og kinoksalyl-metoks y)fenyl-eddiksyrederivater - Google Patents

Substituerte (benzotiazolyl- og kinoksalyl-metoks y)fenyl-eddiksyrederivater

Info

Publication number
NO932031L
NO932031L NO932031A NO932031A NO932031L NO 932031 L NO932031 L NO 932031L NO 932031 A NO932031 A NO 932031A NO 932031 A NO932031 A NO 932031A NO 932031 L NO932031 L NO 932031L
Authority
NO
Norway
Prior art keywords
compounds
straight
chain
substituted
acid derivatives
Prior art date
Application number
NO932031A
Other languages
English (en)
Other versions
NO932031D0 (no
Inventor
Klas Helmut Mohrs
Siegfried Raddatz
Michael Matzke
Buckhard Fugmann
Romanis Fruchtmann
Armin Hatzelmann
Peddinghaus Reiner Mueller
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO932031D0 publication Critical patent/NO932031D0/no
Publication of NO932031L publication Critical patent/NO932031L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/42Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Dot. cr beskrevet substituerte (benzotlazolyl- og klnoksalyl-inetoksy)fenyl-eddiksyrederivater med generel. f orino 1. hvor A, B, I), E og L er like eller forskjellige og kan ha flere betydninger, de kan f.eks. stå for hydrogen, fluor, klor, brom, rettkjedet eller forgrenet alkyl eller alkoksy med Inntil 6 karbonatomer, G står for et svovelatoin eller for gruppen med formelen -N=CH-, Rkan ha flere betydninger og kan bety cyklopenty], cykloheksyl eller cykloheptyl eller rettkjedet eller forgrenet alkyl som evnetuelt er substituert med fenyl , R^ står for hydrogen eller for en gruppe med formelen —OR^, hvor Rf.eks. kan bety hydrogen, rettkjedet eller forgrenet alkyl, Rkan f.eks. bety hydroksy eller rettkjedet eller forgrenet alkoksy med inntil 4 karbonatomer, og salter derav. Forbidelsene fremstilles enten ved omsetning av heterocyklylinetylhalogenforglndelser med tilsvarende fenoksyforbindelser, enten direkte eller med til-knyttet alkylerlng, eller ved omsetning av heterocyklylmetylhalogenforbindelsen med fenoksyforbindelser og etterfølgende omsetning med egnede Grignard-forbindelser. De substituerte (benzotlazolyl— og klnoksalyl-metoksy)fenyl-eddiksyrederivatene kan avendes som virksomme stoffer i legemidler.
NO932031A 1992-06-17 1993-06-03 Substituerte (benzotiazolyl- og kinoksalyl-metoks y)fenyl-eddiksyrederivater NO932031L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4219765A DE4219765A1 (de) 1992-06-17 1992-06-17 Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate

Publications (2)

Publication Number Publication Date
NO932031D0 NO932031D0 (no) 1993-06-03
NO932031L true NO932031L (no) 1993-12-20

Family

ID=6461172

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932031A NO932031L (no) 1992-06-17 1993-06-03 Substituerte (benzotiazolyl- og kinoksalyl-metoks y)fenyl-eddiksyrederivater

Country Status (14)

Country Link
EP (1) EP0574774A1 (no)
JP (1) JPH0665214A (no)
KR (1) KR940000436A (no)
CN (1) CN1084166A (no)
AU (1) AU3981793A (no)
CA (1) CA2098366A1 (no)
CZ (1) CZ109593A3 (no)
DE (1) DE4219765A1 (no)
FI (1) FI932743A (no)
HU (1) HU9301754D0 (no)
IL (1) IL106011A0 (no)
NO (1) NO932031L (no)
SK (1) SK62293A3 (no)
ZA (1) ZA934264B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238307B (it) * 1989-12-22 1993-07-12 Testata per motori alternativi endotermici munita di almeno una valvola comandata sia per aspirazione sia per scarico.
DE4443891A1 (de) * 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE19525028A1 (de) * 1995-07-10 1997-01-16 Bayer Ag Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
JP6557588B2 (ja) 2015-12-04 2019-08-07 株式会社日立ハイテクノロジーズ ドライエッチング方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594425A (en) * 1984-02-09 1986-06-10 American Home Products Corporation Heterocyclic compounds as antiallergic agents
US4675405A (en) * 1984-09-21 1987-06-23 American Home Products Corporation Quinoline compounds as antiallergic and antithrombotic agents
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
IE66512B1 (en) * 1989-02-28 1996-01-10 Ici Plc Heterocyclic ethers as 5-lipoxygenase inhibitors
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4128681A1 (de) * 1991-08-29 1993-03-04 Bayer Ag Substituierte mandelsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4129742A1 (de) * 1991-09-06 1993-03-11 Bayer Ag Heterocyclisch substituierte chinolylmethoxy-phenylacetamide

Also Published As

Publication number Publication date
EP0574774A1 (de) 1993-12-22
DE4219765A1 (de) 1993-12-23
FI932743A0 (fi) 1993-06-15
NO932031D0 (no) 1993-06-03
CZ109593A3 (en) 1994-01-19
JPH0665214A (ja) 1994-03-08
ZA934264B (en) 1994-01-14
CN1084166A (zh) 1994-03-23
KR940000436A (ko) 1994-01-17
FI932743A (fi) 1993-12-18
AU3981793A (en) 1993-12-23
CA2098366A1 (en) 1993-12-18
HU9301754D0 (en) 1993-09-28
SK62293A3 (en) 1994-02-02
IL106011A0 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
SE8200815L (sv) Kemisk forening till anvendning som mellanprodukt vid framstellning av vissa triazolforeningar
CA2279088A1 (en) Fungicidal composition and method for using the same
IE870627L (en) Macrolide compounds
ZA888186B (en) Quinolinecarboxylic acid derivatives
IL114256A0 (en) Agent for the treatment of xerostomia
MX9206679A (es) Nuevo proceso para la preparacion de derivados substituidos de la tiazolidindiona
NO932031L (no) Substituerte (benzotiazolyl- og kinoksalyl-metoks y)fenyl-eddiksyrederivater
EP1036793A3 (en) A process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
AU550807B2 (en) Benzoic or phenyl acetic acid derivatives as plant growth regulators
YU143184A (en) Process for making derivatives of benzo acid having antimicrobic effect
GB1269488A (en) Novel phosphorus-containing triazolothiazole esters, a process for their preparation, and their use as insecticides and acaricides
EP0954974A3 (en) Novel leavening acid composition
AU1586588A (en) Fungicidal derivatives of propenoic acid and processes for their preparation
AU640723B2 (en) 2-formylbenzylphosphonic acid derivatives, their preparation and their use for the treatment of diseases caused by viruses
EP0325788A3 (en) 3,3'-oxy-bis([2,2'-di(bromomethyl)]) propanoic acid derivates, processes for their preparation and their use as flame retardant agents
ES8505178A1 (es) Procedimiento para la obtencion de derivados quinolinicos
KR900018013A (ko) 시아노아세트아미드 유도체, 그의 제조방법 및 그를 유효 성분으로서 함유하는 식물 병해 방제제
ES8204729A1 (es) Procedimiento para la preparacion de acidos de 2-(3'-tienil)propionicos 5'-sustituidos
ATE45723T1 (de) Zimtsaeurepropargylester, verfahren zu ihrer herstellung und ihre verwendung zur schaedlingsbekaempfung.
KR870000349A (ko) 포스폰산 유도체의 제조방법
ATE33139T1 (de) Oximinophosphorsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen.
IE880226L (en) 2-(2,2-difluorocyclopropyl) alkyl esters
JPS6456690A (en) Pyrazoleacetic acid derivative, its production and insecticidal and miticidal agent containing said compound
ES479300A1 (es) Procedimiento de obtencio de &-metil, 4(2'tienil carbonilz) fenil acetato de p-acetamido fenol.
JPS5651483A (en) 1-azaxanthone 3-carboxylic acid derivative and its preparation